AUG 22, 2018 10:38 PM PDT

Biomarker Predicts Kidney Cancer

WRITTEN BY: Nouran Amin

A research study led by Beth Israel Deaconess Medical Center has discovered a tumor biomarker that could be used to determine the onset of renal cell carcinoma (RCC) years before cancer can be diagnosed. The study examined a protein known as KIM-1 which increases in the blood of patients with RCC at the time of diagnosis. The protein can also be utilized to predict the onset of the disease for up to five years prior to diagnosis. Lead investigator of the study, Rupal Bhatt from Harvard Medical School, believes that the study provided evidence of a significant relationship between plasma KIM-1 concentrations and the risk of renal cell carcinoma.

Additionally, the research team found that KIM-1 concentrations were related to poor survival rates. “Further studies are needed, but a sensitive and specific tumor marker that can detect early-stage RCC would have strong potential to improve overall survival," explains Bhatt.

Image Credit: Harish Hospital

Bhatt and research team utilized data from the European Prospective Investigation into Cancer and Nutrition (EPIC). They used this data to compare the blood KIM-1 level in samples taken from individuals who have had RCC within five years with the level of KIM-1 in the blood of healthy individuals. This study was reported in the journal Clinical Cancer Research. Results of the study showed that among the individuals who were eventually diagnosed with RCC the team found that the level of KIM-1 was double the level of those found in healthy participants.

Most importantly, KIM-1 level was integrated into a model for predicting the risk of kidney cancer and the accuracy of the model was increased by approximately two-fold. The co-first author of the study, David Muller, calls the finding as a huge step forward since KIM-1 is the only blood biomarker that known prospectively to differentiate between people’s risk of kidney cancer. However, Muller emphasizes that more work is needed before the blood test can be implemented in the clinic.

“We don't expect that KIM-1 will be useful as a screening test, as the risk of RCC in the general population is low. KIM-1 is more likely to be relevant in high-risk populations or as an adjunct to other diagnostic procedures."

Source: EurekaAlert

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 14, 2019
Chemistry & Physics
SEP 14, 2019
What is Photoacoustic Imaging?
In the last decade, photoacoustic tomography has slowly emerged as a versatile, radiation-free imaging modality that bears great potentials for basic resea...
SEP 22, 2019
Technology
SEP 22, 2019
Blood Incubation Using Laser Technology
The world’s first ever blood incubator was developed using laser technology and could someday prevent fatal blood transfusions in critically ill pati...
OCT 10, 2019
Cardiology
OCT 10, 2019
Parkinson's Disease is Present in the Blood
Parkinson's disease is a progressive disorder of the nervous system. Often starting with a barely noticeable tremor in one hand, the disease affects a...
OCT 24, 2019
Clinical & Molecular DX
OCT 24, 2019
Patients can Self-Inject Easily Using an Integrated Pre-Filled Syringe and Autoinjector
The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. To prevent a monthly visit...
DEC 02, 2019
Cannabis Sciences
DEC 02, 2019
Scientists List Several Reasons Not to Use Marijuana During Pregnancy
An estimated 16 percent of women use marijuana on a daily basis while pregnant, and a large majority of women do so without realizing the potential health...
JAN 28, 2020
Clinical & Molecular DX
JAN 28, 2020
Protein complex discovered as first biomarker of PTSD
  Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR) have identified a potential d...
Loading Comments...